Vansen Pharma Inc.: key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2012)
- -$37.1K
- Total Assets (FY2012)
- $15.0K
- Total Equity (FY2012)
- -$104.5K
- Cash Flows from Operating Activities (FY2012)
- -$28.8K
Source: Vansen Pharma Inc. 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
